Rhinitus/Sinusitis/Ocular Allergy News

AM-301 nasal spray was significantly more effective than saline nasal spray in relieving symptoms and improving health-related quality of life among patients with seasonal allergic rhinitis, according to a study published by Allergy.

People born in fall and winter months in Finland were more likely to develop asthma and allergic rhinitis vs. those born in spring and summer, according to a study published in Allergy.

SoundHealth Inc. has launched SONU, the world’s first FDA-authorized, AI-enabled, over-the-counter, wearable medical device for the treatment of moderate to severe nasal congestion, according to a company press release.

Most patients with rhinitis have suboptimal control of the disease, with errors in nasal spray use and poor adherence to intranasal glucocorticoid treatment, according to a study published in The Journal of Allergy and Clinical Immunology.

Children with asthma, frequent head colds and tonsilitis at age 7 years face greater risks for chronic rhinosinusitis in middle age and may benefit from closer monitoring and proactive management, according to a study published in Allergy.

Patients with allergic rhinitis experience a greater number and diversity of symptoms when they have increasing numbers of sensitizations, according to a study published in Annals of Allergy, Asthma & Immunology.

With allergy season in full swing, primary care providers can expect an increase in patients presenting with rhinitis symptoms.

The FDA has accepted for priority review the supplemental biologics license application of dupilumab for adolescents with chronic rhinosinusitis with nasal polyps, Regeneron Pharmaceuticals Inc. and Sanofi announced in a press release.

Subcutaneous allergen immunotherapy for house dust mite reduced the number of prescriptions for allergic rhinitis and asthma medications, according to a study published in The European Journal of Allergy and Clinical Immunology.